Standardizing flow cytometric assays in long-term population-based studies

Quantification of leukocyte subpopulations and characterization of antigen-expression pattern on the cellular surface can play an important role in diagnostics. The state of cellular immunology on the single-cell level was analyzed by polychromatic flow cytometry in a recent comparative study within the average Leipzig population (LIFE - Leipzig Research Centre for Civilization Diseases). Data of 1699 subjects were recorded over a long-time period of three years (in a total of 1126 days). To ensure compatibility of such huge data sets, quality-controls on many levels (stability of instrumentation, low intra-laboratory variance and reader independent data analysis) are essential. The LIFE study aims to analyze various cytometric pattern to reveal the relationship between the life-style, the environmental effects and the individual health. We therefore present here a multi-step quality control procedure for long-term comparative studies.

[1]  Greg Finak,et al.  Critical assessment of automated flow cytometry data analysis techniques , 2013, Nature Methods.

[2]  L. Ziegler‐Heitbrock,et al.  Reprint of: Monocyte subsets in man and other species. , 2014, Cellular immunology.

[3]  Markus Scholz,et al.  Rationale and Design of the Leipzig (LIFE) Heart Study: Phenotyping and Cardiovascular Characteristics of Patients with Coronary Artery Disease , 2011, PloS one.

[4]  F. Lacombe,et al.  Comparable flow cytometry data can be obtained with two types of instruments, Canto II, and Navios. A GEIL study , 2013, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[5]  A. Villringer,et al.  Prevalence and risk factors of depressive symptoms in latest life—results of the Leipzig Longitudinal Study of the Aged (LEILA 75+) , 2012, International journal of geriatric psychiatry.

[6]  C. E. Pedreira,et al.  Quality assessment program for EuroFlow protocols: Summary results of four‐year (2010–2013) quality assurance rounds , 2015, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[7]  James A. Hutchinson,et al.  Standardization of whole blood immune phenotype monitoring for clinical trials: panels and methods from the ONE study , 2013, Transplantation research.

[8]  I. Heimbeck,et al.  Standardized single‐platform assay for human monocyte subpopulations: Lower CD14+CD16++ monocytes in females , 2010, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[9]  G. Heine,et al.  Monocyte subsets in atherosclerosis , 2014, Hämostaseologie.

[10]  A. Tárnok,et al.  OMIP‐023: 10‐Color, 13 antibody panel for in‐depth phenotyping of human peripheral blood leukocytes , 2014, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[11]  J. Dukart,et al.  Age Correction in Dementia – Matching to a Healthy Brain , 2011, PloS one.

[12]  G. Ma,et al.  Intermediate monocytes lead to enhanced myocardial remodelling in STEMI patients with diabetes. , 2015, International heart journal.

[13]  T. Grodzicki,et al.  Blood Monocyte Subsets and Selected Cardiovascular Risk Markers in Rheumatoid Arthritis of Short Duration in relation to Disease Activity , 2014, BioMed research international.